Nigerian-born doctor and scientist Dr Funmi Olopade is one of the world’s leading authorities on hereditary breast cancer and cancer risk assessment. She has a special interest in women of African descent, and her research into the genetic basis of breast cancer in young women of African ancestry has broadened our understanding of the interactions between genes, lifestyle and the environment in the development of breast cancer.

In October 2008, in recognition of her work, Dr Olopade was elected to the Institute of Medicine of the National Academy of Sciences and in February 2011, Dr Olopade was nominated by President Barack Obama for membership on the National Cancer Advisory Board.

Dr Olopade directs a multidisciplinary clinical and laboratory research program at the University of Chicago Medical Centre, is a haematology oncologist and the Walter L Palmer Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago.

Dr Olopade has received numerous honours and awards, including honorary degrees from North Central, Dominican, Bowdoin, and Princeton universities. She is also a recipient of the Doris Duke Distinguished Clinical Scientist and Exceptional Mentor Award, an American Cancer Society Clinical Research Professorship, a MacArthur Foundation “Genius” Fellowship and Officer of the Order of the Niger Award.